|
Lacore Labs to market Aivita Biomedical's new skincare products in Asian countries
|
|
Irvine, California
May 31 , 2019
|
|
|
Aivita Biomedical, a privately held company engaged in the advancement
of commercial and clinical-stage programs utilizing curative and
regenerative medicines, has announced the execution of a deal with
custom formulator and beauty product developer Lacore Laboratories.
The
deal allows for the use of Aivita’s proprietary actives complex in a
new line of skincare products to be distributed by Lacore’s subsidiary
Generation New Online across greater Asian countries. Consumers in Hong
Kong, Taiwan, Singapore, Malaysia and Mainland China will be among the
first to have access to the new line.
Aivita’s proprietary active
technology is a science-based multi-functional ingredient complex and
delivery system which captures the natural cell messaging system and
ingredients of skin stem cells. The active contains a complete and
balanced mix of all the naturally-occurring, revitalizing factors
present in a young skin environment.
“Lacore brings unique
capabilities to Aivita, including their cultural knowledge of product
preferences and their distribution prowess throughout Asia”, said Dr.
Hans Keirstead, chairman and chief executive officer of Aivita
Biomedical, “We’re thrilled to be bringing our revolutionary active
technology to consumers throughout the world”.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|